145 related articles for article (PubMed ID: 36678670)
1. Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A.
Kang C; Kim J; Ju S; Cho H; Kim HY; Yoon IS; Yoo JW; Jung Y
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678670
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y
Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent.
Lee H; Park S; Ju S; Kim S; Yoo JW; Yoon IS; Min DS; Jung Y
Mol Pharm; 2021 Apr; 18(4):1730-1741. PubMed ID: 33661643
[TBL] [Abstract][Full Text] [Related]
4. A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats.
Kim S; Lee S; Lee H; Ju S; Park S; Kwon D; Yoo JW; Yoon IS; Min DS; Jung YS; Jung Y
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899177
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
[TBL] [Abstract][Full Text] [Related]
6. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis.
Kim W; Kim D; Jeong S; Ju S; Lee H; Kim S; Yoo JW; Yoon IS; Jung Y
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31703411
[TBL] [Abstract][Full Text] [Related]
8. A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug.
Park S; Kang C; Kim J; Ju S; Yoo JW; Yoon IS; Kim MS; Lee J; Jung Y
Mol Pharm; 2022 Nov; 19(11):3784-3794. PubMed ID: 36043999
[TBL] [Abstract][Full Text] [Related]
9. Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation.
Kim W; Kim S; Ju S; Lee H; Jeong S; Yoo JW; Yoon IS; Jung Y
Mol Pharm; 2019 Sep; 16(9):4007-4016. PubMed ID: 31386809
[TBL] [Abstract][Full Text] [Related]
10. Dapsone Azo-Linked with Two Mesalazine Moieties Is a "Me-Better" Alternative to Sulfasalazine.
Kang C; Kim J; Ju S; Park S; Yoo JW; Yoon IS; Kim MS; Jung Y
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336057
[TBL] [Abstract][Full Text] [Related]
11. N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.
Kim J; Kang C; Yoo JW; Yoon IS; Jung Y
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004616
[TBL] [Abstract][Full Text] [Related]
12. Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement.
Yum S; Jeong S; Lee S; Nam J; Kim W; Yoo JW; Kim MS; Lee BL; Jung Y
Drug Des Devel Ther; 2015; 9():4247-58. PubMed ID: 26273188
[TBL] [Abstract][Full Text] [Related]
13. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug.
Park H; Kim W; Kim D; Jeong S; Jung Y
Curr Mol Pharmacol; 2019; 12(4):272-280. PubMed ID: 30848228
[TBL] [Abstract][Full Text] [Related]
15. Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.
Lee Y; Kim W; Hong S; Park H; Yum S; Yoon JH; Jung Y
Eur J Pharmacol; 2014 Mar; 726():49-56. PubMed ID: 24462351
[TBL] [Abstract][Full Text] [Related]
16. Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent.
Kim W; Lee Y; Jeong S; Nam J; Lee S; Jung Y
Arch Pharm Res; 2015 Oct; 38(10):1830-8. PubMed ID: 25860026
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice.
Zhu B; Shang B; Li Y; Zhen Y
Mol Med Rep; 2016 May; 13(5):4159-66. PubMed ID: 27035417
[TBL] [Abstract][Full Text] [Related]
19. Sodium Butyrate Attenuates Diarrhea in Weaned Piglets and Promotes Tight Junction Protein Expression in Colon in a GPR109A-Dependent Manner.
Feng W; Wu Y; Chen G; Fu S; Li B; Huang B; Wang D; Wang W; Liu J
Cell Physiol Biochem; 2018; 47(4):1617-1629. PubMed ID: 29949795
[TBL] [Abstract][Full Text] [Related]
20. Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.
Hong S; Yum S; Yoo HJ; Kang S; Yoon JH; Min D; Kim YM; Jung Y
Mol Pharm; 2012 May; 9(5):1310-9. PubMed ID: 22428658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
